Agilent Technologies had 19 patents in future of work during Q2 2024. Agilent Technologies Inc filed patents in Q2 2024 for methods to distinguish tissue from embedding medium using fluorescence, automated tissue sectioning and transferring onto slides, and allocating functional tasks to analytical devices based on predefined processes and control targets. GlobalData’s report on Agilent Technologies gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Agilent Technologies had no grants in future of work as a theme in Q2 2024.
Recent Patents
Application: Preparation of tissue sections using fluorescence-based detection (Patent ID: US20240183763A1)
The patent by Agilent Technologies Inc. describes an improved method for distinguishing tissue from an embedding medium in formalin-fixed paraffin-embedded samples using fluorescence. The method involves irradiating the sample with light, detecting the fluorescence emission, and determining the tissue's location based on this emission. The technique can be used to locate tissue surfaces, trim sections, and stain tissues for further analysis.
Additionally, the patent outlines a method involving multiple light sources to produce different fluorescence emissions for locating tissue in embedded samples. The apparatus described includes a microtome with a sample holder and knife for slicing tissue sections, along with light sources and an optical system to capture emitted light. This innovative approach can enhance the accuracy and efficiency of tissue analysis in research and diagnostic applications.
To know more about GlobalData’s detailed insights on Agilent Technologies, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.